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Histocompatibility-linked specific  immune response  (Jr) I  genes,  controlling the 
ability to  develop cellular and humoral immune responses,  have been identified in 
guinea pigs  and mice  (1).  Two experimental approaches  used to  identify Ir genes 
and  to  investigate their function have  been the  study of  immunogenicity of  syn- 
thetic polypeptides of  limited structural diversity, and  the  study of  the  immuno- 
genicity of native protein antigens injected in limiting immunizing doses.  In earlier 
reports we have identified four Ir genes  in inbred and random-bred guinea pigs,  the 
"PLL, .... GA, .... GT,"  and  "L-BSA"  genes  controlling, respectively,  immune re- 
sponsiveness to hapten-poly-L-lysine  conjugates, to random eopolymers of L-glutamic 
acid and L-alanine (GA), and to L-glutamic acid and L-tyrosine (GT), and to limiting 
immunizing doses of bovine serum albumin (BSA)  (2-4). 
Inbred strain 2 guinea pigs are homozygous for the PLL,  GA,  and L-BSA genes 
which were  shown to be very closely  linked to  the major locus controlling strain 2 
histocompatibility antigens (4-7). The GT gene is found in strain 13 guinea pigs and 
is similarly linked to a major strain 13 histocompatibility  specificity (7). Furthermore, 
in most random-bred guinea pigs the GA and PLL genes remain linked and behave 
as alleles or pseudoalleles to the GT gene (8). 
The successful  transfer of immune responsiveness controlled by the PLL gene to 
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irradiated  strain  13 nonresponder recipients with lymph node and spleen cells  from 
(2  ×  13)F1 responder  donors and  the observation that  the responding cells  in the 
chimeric animals were of donor origin demonstrate the expression of Ir genes in im- 
munocompetent cells  (9,  10). There is, in addition, considerable evidence for the ex- 
pression  of histocompatibility-linked  Ir  genes  in  cells  concerned with  cellular  im- 
munity and with "helper" or "carrier" function in antibody responses. Thus, delayed 
hypersensitivity  and  in vitro  correlates  of cellular  immunity are  observed  only in 
animals possessing the specific Ir gene required to respond to the corresponding antigen 
(2,  3).  Further,  a  specific  Ir gene,  controlling responsiveness  to a  carrier  molecule, 
controls also anti-hapten antibody responses to all hapten conjugates of this molecule 
(2).  Correspondingly, nonresponder animals lacking the PLL gene can nevertheless 
be induced to form antibodies  but not cellular immunity against DNP-PLL, when 
immunized with DNP-PLL complexed with an immunogenic albumin (12). 
The mechanism  of action of specific Ir genes  in immunocompetent  cells  is 
not clear. In addition to their expression in cells mediating cellular immunity, 
specific  Ir  genes  may  affect  the  specificity  of  the  antibody  population  pro- 
duced  in  some systems.  This  puzzling  effect  is  observed  in  spite  of the  fact 
that  the  antibodies  produced  in  response  to  antigens  under  unigenic  control 
are  markedly  heterogeneous  with  regard  to  class,  specificity,  and  affinity. 
In  the  present  study  we have  taken  advantage  of the  immunogenicity  of  a 
random  terpolymer  of L-glutamic  acid,  L-alanine,  and  L-tyrosine  (GAT)  for 
all strain  2,  strain  13,  and random-bred Hartley guinea pigs  (3)  to study the 
effect  of the  GA  and  GT  genes  on the  specificity  of immune  responses  to  a 
more  complex  antigen.  Since  GAT  presumably  contains  GA  and  GT  deter- 
minants  in addition  to antigenic determinants  unique to itself,  we felt  that  a 
comparative study of the specificities of cellular and humoral responses to GAT 
made  by genetic responder  and  nonresponder  animals  may clarify the  role of 
Ir genes in immune responses to complex antigens. 
Materials and Methods 
Polymers.--Poly-ol-[L-glutamic acid  (60%), L-alanine (40%)], GA, tool wt 43,000; poly- 
o~-[L-glutamic  acid (60%), L-alanine (30%), L-tyrosine (10%)], GAT, mol wt 25,000; poly-cz- 
[L-glutamic acid  (60%), L-lysine (40%)], GL, tool wt 115,000; and poly-L-lysine, PLL, tool 
wt  110,000 were obtained  from Pilot Chemical Division of New England  Nuclear  Corp., 
Boston, Mass. 
Poly-a-[g-glutamic acid (50%), L-tyrosine (50e/~)], GT, mol wt 14,500 was obtained from 
Miles Laboratories,  Kankakee,  Ill. 
DNP37-PLL was  made  by reacting  poly-L-lysine with  2,4-dinitrofluorobenzene  as pre- 
viously described (13). The subscript refers to the average number of dinitrophenyl  (DNP) 
groups per molecule. 
Animals.--The inbred  strain  2 and strain  13 guinea pigs and some of the random-bred 
Hartley guinea pigs used  in this  study were obtained  from the Animal Production  Unit, 
National  Institutes of Health,  Bethesda, Md. Other Hartley guinea pigs used were obtained 
from Camm Research Laboratories,  Inc., Wayne, N. J. Carom Hartley guinea pigs have a 
lower GA and PLL and a higher  GT gene frequency  than the NIH Harfley animals.  All 
animals used in this study weighed between 250 and 450 g when immunized. 100  GENE-DETERMINED  SPECIFICITY  OF  IMMUNE  RESPONSES 
Immunization Procedures.--Antigen solutions in 0.015 M phosphate buffer, pH  7.5,  con- 
taining 0.15 BI  NaC1  (PBS)  were  emulsified  with an  equal  volume  of  complete  Freund's 
adjuvant containing 0.5 mg/ml Myobacterium butyricum (Difco Laboratories, Inc., Detroit, 
Mich.). The immunizing dose was 500/~g of GAT, GA, or GT administered in 0.4 ml of the 
emulsion distributed in the four foot pads. The guinea pigs that were immunized with GAT 
and DNP-PLL simultaneously received 500/zg of GAT and 100/zg of DNP-PLL,  each con- 
tained in 0.2 ml of the adjuvant emulsion distributed in a front and rear foot pad. 
Skin Tests.--3 wk after immunization the guinea pigs were challenged with intradermal 
injections of the appropriate antigens. The concentrations were adjusted so that the animals 
received 50 gg of the glutamic acid containing polypeptides or 10 gg of DNP-PLL in 0.1 ml 
of  normal saline. The injection sites were examined 24 hr later.  Erythema and induration 
significantly greater than observed in unimmunized control animals was considered a positive 
skin test. 
Antibody Assay.--The  guinea pigs were  bled  from  the  retro-orbital venous plexus just 
before skin testing and the sera were assayed for antibody against the immunizing polymer 
as  well as  for  antibodies cross-reacting with  other  synthetic antigens, using  the  modified 
Farr-type assay described previously  (3).  Radioactive ligands, made by iodinating GT and 
GAT polymers with  12~I, using the chloramine-T method  (14),  were  used  to  detect anti- 
bodies specific for those antigens. A  ligand capable of detecting anti-GA antibodies in sera 
containing anti-GAT antibodies was prepared by binding covalently GA with human serum 
albumin (HSA) and subsequently iodinating the complex with 125I. The complex was formed 
by reacting GA (10 mg), HSA (10 rag), and 1-ethyl-3-(3-dimethylamino propyl) carbodiimide 
hydrochloride (200 mg)  in 0.2 ~[ carbonate buffer, pH 9.8,  in a  total volume of 1.2 ml. The 
reaction mixture was stirred continuously at room temperature for 30 min and then dialyzed 
against 2000 vol of PBS overnight. The GA-HSA complex was separated from free GA and 
free albumin on the basis of their different electrophoretic mobility using Geon block prepara- 
tive electrophoresis. The Geon resin was obtained from B. F.  Goodrich Chemical Company, 
Louisville, Ky. The complex was eluted from the Geon with normal saline, concentrated by 
vacuum dialysis, and iodinated by the chloramine-T method  (14).  A  maximum 70% of the 
complex, GA-HSA-125I,  was bound by strong specific anti-GA guinea pig antisera. 
Culture Conditions.--Axillary, inguinal, and popliteal lymph nodes were  removed under 
sterile conditions 3-6 wk after immunization and teased into a single cell suspension in Eagle's 
minimal essential medium. 5 million cells were placed in 12  X  75 mm plastic culture tubes 
with a  final volume of 1.5 ml containing 5% fetal bovine serum and various concentrations 
of  the test antigens as indicated. Each experimental group  consisted of triplicate cultures. 
They were incubated at 37°C in a  5% CO2 in air atmosphere. After 48 hr 1/ICi of thymidine- 
methyl-3H (1.9 Ci/mmole) was added to each tube and incubation continued another 24 hr. 
The cultures were harvested by trapping the cells  on Millipore filters, washing twice with 5 
ml of  PBS  containing 0.001 ~  thymidine,  twice with 5  ml 5/%  trichloroacetic acid  (TCA) 
containing 0.001 ~  thymidine, and once with 5 ml 95/% ethanol. The wet filters were placed 
directly in the scintillation fluid (Aquasol, New England Nuclear Corp., Boston, Mass.) and 
counted in a  liquid scintillation spectrometer. 
RESULTS 
Immunological  Specificity  of Anti-GA  and  Anti-GT  Responses.--No  cross- 
reactivity between delayed hypersensitivity skin reactions specific for GA  and 
GT  could  be  detected  (Table  I).  After  immunization  with  GA,  9  of  10  NIH 
Hartley  guinea  pigs  demonstrated  delayed  skin  reactivity  to  GA.  All  nine 
GA responders were  also sensitive to  GAT,  but  none of the animals displayed 
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amino acid composition of GA and GAT, which is GA with 10% added L-tyro- 
sine, probably accounts for their high degree of cross-reactivity in GA responder 
animals. After GT immunization, 8 of 10 Camm Hartley guinea pigs developed 
delayed skin reactivity. None of these animals showed sensitivity to either GA 
or GL. However, only two of the eight GT responders also responded to intra- 
dermal  challenge  with  GAT.  GAT probably does  contain  GT determinants, 
but this must represent a  small part of the molecule, which  accounts for the 
limited cross-reactivity observed with GT. 
The  lack  of  cross-reactive delayed skin  reactions  between  GA  and  GT  is 
mirrored in vitro  (Table II). Cultured  lymph node  cells from GA responder 
Hartley guinea pigs respond to  GA stimulation with  increased tritiated  thv- 
TABLE I 
The Specificity of Delayed Hypersensitivity Reactions in Hartley Guinea  Pigs Immunized  with 
GA  or GT 
Animals with delayed  Immunizing  polymer  Skin testing polymer  sensitivity/animals  immunized 
100 ~g  50 ,~g 
GA  GA  9/10" 
GT  0/10 
GL  0/10 
GAT  9/10" 
GT  GT  8/10t 
GA  0/10 
GL  0/10 
GAT  2/10~ 
* The same nine animals reacted to GA and to GAT. 
:~ Two of the GT-sensitive animals reacted to GAT. 
midine  (TdR-3H)  incorporation.  The  increase  was  fourfold  on  the  average 
over the tritiated thymidine incorporation of the same cells not stimulated by 
GA.  GA  does  not  stimulate  cells  from genetic  nonresponders  nor  does  GT 
induce  increased  TdR-3H  incorporation  in  the  cells  from  GA  responders. 
Similarly, lymph node cells from GT responder guinea pigs, but not from GT 
nonresponders, are stimulated in vitro by GT. The responder cells are stimu- 
lated by GT in vitro also with  a  fourfold average increase in TdR-3H incor- 
poration, but do not respond at all to GA. 
There is no detectable cross-reactivity between anti-GA  and anti-GT anti- 
bodies produced  by genetic  responder Hartley guinea pigs  (Table  III). The 
anti-GA  antibodies  in sera obtained 3  wk after immunization with  GA bind 
the  GA-HSAJ25I and GAT-125I ligands but do not bind GT-12~I. The GAT is 
consistently a more sensitive ligand for the detection of anti-GA antibody than 
is  the  GA-albumin complex perhaps because the  tertiary  structure  of  GA  is 102  GENE-DETERMINED  SPECIFICITY  OF  IMMUNE  RESPONSES 
altered by coupling it to the protein. Similarly, anti-GT antibody binds GT-~25I 
and  GAT-~25I  but  does  not  bind  the  GA-HSA-125I ligand.  The  GAT  and  GT 
ligands  are  approximately  equally sensitive for the  detection  of anti-GT  anti- 
body. 
TABLE  II 
The Specif~ity qf Antigen-Stimulated  Tritiated  Thymidine  Invorporation in Lymph Node Cell 
Cultures from Hartley Guinea Pigs Immunized with GA or GT 
Immunizing  Responder  Challenging  TdR-zH incorporation 




mean  (range) 
--  GA  3  0.92  (0.85-1.0) 
+  GA  4  4.0  (3.2  -5.1) 
4-  GT  4  1.0  (0.89-1.2) 
--  GT  5  0.88  (0.76-1.1) 
4-  GT  6  4.4  (2.7  -6.0) 
4-  GA  5  1.1  (0.94-1.2) 
* Responders  (+)  demonstrated  both  delayed  skin  reactivity and  serum  antibody  di- 
rected  against  the  immunizing polymer.  Nonresponders  (-)  made no detectable immune 
responses to the immunizing polymer. 
:~ GA was added to the cultures at a  concentration of 100 pg/ml. GT was added  to the 
cultures at a concentration of 10 ~g/ml. These doses elicited the maximal responses in cultures 
of cells from responder animals. 
cpm incorporated in stimulated cultures 
§ E/C  = 
cpm incorporated in cultures receiving no antigen " 
TABLE  III 
The Specificity  of Serum  Antibody  Produced by Responder Hartley Guinea Pigs Immunized 
with GA or GT 
No. of animals  Immunizing  Per cent binding* 
polymer  GAT- 1 ~  ~  I  GA-HSA- 1  ~  51  GT-1 ~  ~  I 
500 lag~animal 
9  GA  71.3  (53-86)~  47.2  (34-62)  1.9  (0-5) 
7  GT  39.9  (28-61)  1.9  (0-4)  48.9  (17-63) 
* The per cent GAT-I2sI (5 mgg), GA-HSA-I~5I  (0.4 #g), and  GT-125I (3 mgg) bound by 
the globulin fraction of 0.05 ml of a  1 : 10 dilution of the test serum using the assay proce- 
dure  described previously  (3).  Excess antibody  can  bind  over 90%  of the  GAT and  GT 
ligands, but a  maximum of only 70% of the GA-HSA-t25I ligand. 
++ The data is expressed as the arithmetic mean with the range in parentheses. 
Cross-Reactivity  of Anti-GAT  Responses for GA.--In  order  to  assess  the in- 
fluence of a  specific immune response gene on the immune  responses  to a  more 
complex  antigen,  we  have  examined  the  specificity  of  both  cellular  and  hu- 
moral  immune  responses  to  GAT  for  cross-reactivity  directed  toward  GA. 
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develop  delayed hypersensitivity  and  circulating  antibody  directed  against 
GAT  (3).  However,  when  tested  for  cross-reactivity  directed  against  GA, 
the anti-GAT sera from strain 2 guinea pigs which possess the GA gene were 
able to bind significantly the GA-HSA-I~sI  ligand while none of the anti-GAT 
sera from strain  13  guinea pigs  (GA  nonresponders)  had  antibodies  capable 
of binding GA (Table IV). Since the strain 2 guinea pigs develop higher anti- 
GAT antibody levels than do the strain 13 animals, we have expressed the data 
as a ratio of the per cent GA bound to the per cent GAT bound. Clearly, the 
presence of the GA gene influences the specificity of the  anti-GAT antibody 
population produced. 
In most random-bred Hartley guinea pigs the GA gene is linked to the PLL 
gene (8). We can, therefore, identify most Hartley animals possessing the GA 
TABLE IV 
The Effect of GA Responder  Status on the Specificity for GA of Anti-GAT Antibodies  Produced 
by Strain g and Strain 13 Guinea Pigs 
Strain  No. of  No. with  Anti-GA specificity per cent  Per cent anti-GA binding 
anti-GA  binding~;  Per cent anti-GAT binding  animals  specificity* 
Mean  (sE)  Mean  (SE) 
2  7  7  30.8  (4.41)  0.41  (0.051) 
13  5  0  2.2  (1.39)  0.03  (0.020) 
* Greater than 10% antigen binding is required to demonstrate the presence of specific 
antibody in this assay based on the highest nonspecific binding of GA-HSA-I~I observed 
with a control panel of normal sera. 
:~ The per cent binding of GA-HSA-125I was determined as described in the legend to 
Table III. 
gene by testing for PLL responsiveness. After simultaneous immunization of 
Carom Hartley guinea pigs with GAT and DNP-PLL, all of the animals de- 
veloped delayed skin reactivity to GAT and circulating anti-GAT antibody, as 
expected.  However,  when  skin  tested  for  cross-reactivity to  GA,  with  few 
exceptions, only those animals expected to possess the GA gene, on the basis 
of their responsiveness to DNP-PLL, demonstrated delayed hypersensitivity 
to GA (Table V). Positive GA skin tests developed in all but one of the eight 
PLL responders, and in only two of eleven PLL nonresponders. The two PLL 
nonresponders  demonstrating  cross-reactivity  with  GA  and  the  one  PLL 
responder not cross-reacting with GA are consistent with the number of ani- 
mals expected in this population in which the GA and PLL immune response 
genes are not linked (8). Thus, the GA immune response gene also determines 
the  specificity  of  delayed  hypersensitivity  responses  induced  by  GAT  im- 
munization. 
The specificity of the antibodies produced by these GAT-immunized Hartley 
guinea  pigs  is  also  influenced by the  presence  of the  GA  gene  (Table VI). 104  GENE-DETERI'c[INED  SPECIFICITY  OF  II~MUNE  RESPONSES 
Although  the  amount  of  circulating  anti-GAT  antibody  produced  by  GA 
responders  and  nonresponders  is  similar,  antibodies  capable  of  binding  GA 
specifically were detected only in the  antisera from  GAT-immunized animals 
showing  delayed hypersensitivity to  GA,  and  thus  possessing  the  GA  gene. 
Cross-Reactivity  of A nli-GA T  Responses for GT.--A  study of the specificity 
of cellular and humoral  anti-GAT responses for GT was made in strain 2 and 
TABLE V 
The Relationship between PLL Responder Status and Ddayed Hypersensitivity to GA in Hartley 
Guinea Pigs Immunized with GA T 
PLL status*  No. of animals with D.H. to GATI  No. of animals with D.H. to GA** 
Responder  8  7 
Nonresponder  11  2 
* Responder  status  to  DNP-PLL  based  on  delayed skin reactivity to  DNP-PLL and 
circulating anti-DNP antibody 3 wk after simultaneous immunization with DNP-PLL and 
GAT as described in Materials and Methods. 
:~ Delayed hypersensitivity (D.H.) to GAT and GA was determined by skin test with 50 
/Jg of those polypeptides 3 wk after immunization. 
TABLE VI 
The RdationsMp between Ddayed Hypersensitivity to GA  and Anti-GA  Antibodies in Sera of 
Itartley Guinea Pigs Immunized to GA T 
GA respondcr  No. of animals  Anti-GA specificity per cent binding**  Anti-GAT antibodies 
status*  per cent binding~ 
Mean  (sE)  Mean  (sE) 
+  9  22.9  (6.8)  79.2  (2.8) 
--  I0  4.7  (1.7)  74.0  (3.2) 
* Those  GAT-immunized  animals  showing  cross-reactive  delayed  hypersensitivity to 
GA are indicated (+), those not cross-reacting to GA (--). 
:~ The per cent binding of GA-HSA-I~I and  GAT-12~I was determined as  described  in 
the legend to "fable III. 
in  strain  13  guinea  pigs  immunized  with  the  terpolymer.  The  five  strain  2 
and 10 strain 13 guinea pigs immunized with 500  ~g of GAT developed strong 
delayed  hypersensitivity reactions  against  the  immunizing  polypeptide  and 
produced normal  anti-GAT antibody responses. None  of these  animals, how- 
ever, showed delayed sensitivity cross-reactions to GT.  No difference was  ob- 
served in this respect between strain 2 guinea pigs lacking  and strain 13  pos- 
sessing the GT gene. The ability of the  anti-GAT sera from the two groups to 
bind GT-125I  is shown  in Table VII. In sharp contrast with the  demonstrated 
dependence  of  anti-GA cross-reacting antibodies  on  the  presence  of  the  GA 
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antibodies capable of binding GT in  response to GAT without any detectable 
influence of the GT gene. It was not ascertained, however, if these antibodies 
are identical or different from anti-GT antibodies produced by strain 13 guinea 
pigs immunized with GT itself. 
TABLE  VII 
The Effect of GT Responder Status on the Specificity for GT of A nti-GA T  A ntibodies  Produced 
by Strain 2 and Strain 13 Guinea Pigs 
Strain  No. of animals  Anti-GAT antibodies per cent binding*  Anti GT  specificities  per cent binding* 
Mean  (SE)  Mean  (SE) 
2  5  77.3  (3.00)  54.3  (2.54) 
13  10  53.0  (5.48)  26.1  (3.72) 
* The  per  cent  binding  of  GAT-125I  and  GT-125I  were  determined  as  described  in  the 
legend to Table III. 
DISCUSSION 
After immunization with GA or GT, guinea pigs possessing the appropriate 
specific  immune  response  genes  develop  both  delayed hypersensitivity  and 
antibody directed against  the  immunizing  antigen,  but  despite the  fact that 
both GA and GT are composed of at least 50% randomly distributed glutamic 
acid residues,  the  immune  responses induced by these synthetic antigens  do 
not cross-react. Responder guinea pigs immunized with GA do not react either 
in vivo or in vitro to challenge with GT, nor do their antisera bind GT. Simi- 
larly, anti-GT responses do not cross-react with  GA. A  high degree of cross- 
reactivity was observed, however, between delayed hypersensitivity responses 
to GAT and GA. All genetic responder guinea pigs immunized with  GA dis- 
played strong reactivity to GAT, whereas delayed hypersensitivity to GA in 
GAT-immunized animals depended upon the presence of the GA gene. 
In contrast, the cross-reactivity between cellular immunity to GT and GAT 
was very poor. A small fraction of GT responder guinea pigs immunized with 
this antigen showed weak cross-reactive sensitivity to GAT, and none of the 
animals immunized with GAT displayed reactivity to GT, irrespective of their 
responder status to this antigen. The difference in the cross-reactivity of cellular 
immunity to GAT in  CA-  and  GT-immunized animals  probably reflects the 
considerably greater  similarity of  CAT  with  GA  than  with  GT.  The  GAT 
preparation used in this study contains L-glutamic acid  and L-alanine in  ap- 
proximately the same ratio as in GA, with only 10% L-tyrosine, while GT is 
composed of 50% L-glutamic acid and 50% L-tyrosine residues. 
The data demonstrate that the activity of a specific Ir gene, the GA gene, 
is  required for the  development of GA-specific cellular immunity in  animals 
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how  the  specificity of  delayed hypersensitivity against  a  relatively complex 
antigen is determined by the genetic ability of the animal to respond to defined 
sequences in the molecule. These results are evidence that the cellular immune 
response  to  complex  antigens  is  under  multiple  gene  control  and  that  the 
specificity of these responses is determined by the Ir gene constitution of the 
individual.  The  absolute  dependence of the  expression of cellular immunity 
on the possession of the relevant Ir gene is consistent with the expression of 
histocompatibility-linked specific Ir genes in thymus-derived cells. 
In  addition to  determining,  in  part,  the specificity of cellular immune  re- 
sponses to GAT, the GA gene is also able to affect the specificity of the anti- 
GAT antibody population. In both inbred and random-bred guinea pigs after 
immunization with GAT, antisera obtained from only those animals possessing 
the GA gene were able to bind GA significantly. The anti-GAT sera obtained 
fronl animals lacking the GA gene, on the other hand, had no detectable cross- 
reactivity directed  against  GA.  Similar  genetic  influences  on  the  specificity 
of the  antibody populations produced has  been  observed in the  response to 
other synthetic polypeptides. Pinchuck and Maurer (15) demonstrated in mice 
a  genetic influence in the cross-reactions to a synthetic antigen. They used a 
terpolymer of ~-glutamic acid, L-lysine, and l.-alanine containing 40 % alanine 
residues  (GLA4o) which  is  immunogenic  in  all  mice  tested.  When  the  anti- 
GLA4o sera produced by three different inbred mouse strains were tested for 
cross-reactivity,  anti-GL  specificity  was  found  in  the  sera  from  C3H/HeJ 
mice but not in the sera of C57BL/6J or 129/J mice. While clearly indicating 
a genetic influence on the specificity of the antibody produced to GLA40, these 
results  do  not  relate  the  specificity differences to  specific  immune  response 
genes, since GL itself has been shown to be nonimmunogenic in mice. Mozes 
et  al.  (16)  studying  antibody  responses  to  synthetic  polypeptides  built  on 
multichain  polyprolines, have  demonstrated  the  effect of Ir  genes  in  deter- 
mining  the  specificity of  antibodies  produced by different mouse  strains  to 
the  same  antigen.  Two  inbred  mouse  strains,  DBA/1  and  SJL,  immunized 
with  (Phe,G)-Pro--L produce similar  amounts  of anti-(Phe,G)-Pro--L anti- 
body,  but  the  specificity of  the  antisera  toward  the  cross-reactive  antigen 
(Phe,G)-A--L is markedly different. The ability of anti-(Phe,G)-Pro--L sera 
from the  progeny of the  reciprocal backcross mating  of (DBA/1  X  SJL)F1 
animals with  SJ-L mice to bind  (Phe,G)-A--L segregates with H-2  genotype. 
The ability of these mice  to bind  (Phe,G)-A--L is linked  to  the 1-1-2 q  locus 
(17),  as is  their ability to respond to immunization with  this  antigen.  These 
findings  are quite  analogous to the  results we have presented in this  report. 
Thus,  in  both  mice  and  guinea  pigs,  specific  immune  response  genes  may 
affect the specificity of the antibody population produced against  certain com- 
plex polypeptide antigens. 
However, this effect of histocompatibility-linked Ir genes on the specificity 
of humoral  antibody is  not  universally observed with  all  determinants.  For BLUESTEIN,  GREEN,  MAURER,  AND  BENACERRAF  107 
instance, anti-hapten responses are generally not affected in this way (11,  18, 
19). The response to immunogenic carrier molecules under unigenic control is 
accompanied with strong antibody production against  any hapten  associated 
with  them,  illustrating  the  specific  cooperation  between  thymus-derived 
cells  and  antibody-secreting  cells  with  different  specificity.  Furthermore  in 
our study, strain 2 guinea pigs lacking the GT gene produced anti-GAT anti- 
bodies  capable  of  binding  GT  as  well  as  those  produced  by  GT  responder 
strain  13  guinea  pigs.  There is  no  obvious  explanation for  our  inability  to 
demonstrate  a  GT gene effect on the  anti-GAT antibody population in  the 
inbred strain other than the possibility that GT may be efficiently bound by 
antibodies elicited by unique GAT determinants. 
It is also difficult to explain the process by which a specific Ir gene expressed 
in thymus-derived cells can affect in some systems the specificity of the anti- 
body population produced to more complex antigens  as shown in our experi- 
ments for the GA gene and also in the reports discussed above (15,  16). Several 
possibilities must  be considered: The activity of the gene in thymus-derived 
cells may determine the mode of presentation of the antigen to the antibody- 
producing  cell precursors  and  thereby  affect the  nature  of the  active deter- 
minants  recognized.  Alternatively  the  gene  may  determine,  directly  or  in- 
directly, as suggested by Jerne (20) the structure and specificity of the antibody 
combining  site.  We  tend  to  favor  the  first  possibility  based  upon  the  pre- 
dominant effects of specific Ir genes on cellular immunity and carrier function. 
SUMMARY 
The ability of guinea pigs to make immune responses to the random linear 
copolymer of L-glutamic acid and L-alanine,  GA,  and to L-glutamic acid and 
L-tyrosine, GT, is each controlled by a different immune response gene. On the 
other hand,  the  random linear terpolymer of L-glutamic acid,  L-alanine,  and 
L-tyrosine, GAT, which contains both GA and GT antigenic determinants, is 
immunogenic in all guinea pigs. After GAT immunization, all animals develop 
delayed hypersensitivity and serum antibody specific for GAT. However, only 
those guinea pigs possessing the GA immune response gene demonstrate cross- 
reactive delayed hypersensitivity when challenged with  GA. In addition, the 
anti-GAT  antisera produced by those  animals  having  the  GA  gene  contain 
cross-reacting anti-GA antibodies. The sera from guinea pigs lacking the GA 
gene have no anti-GA antibody activity. Thus, we have demonstrated that a 
specific immune response gene controlling responsiveness to a "simple" antigen 
can determine the specificity of both cellular and humoral immune responses 
to a more complex antigen. 
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